- Home
- IMNM vs XPEL Comparison
IMNM vs XPEL Comparison
Compare IMNM & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- XPEL
- Stock Information
- Founded
- IMNM 2006
- XPEL 1999
- Country
- IMNM United States
- XPEL United States
- Employees
- IMNM N/A
- XPEL N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- XPEL Industrial Specialties
- Sector
- IMNM Health Care
- XPEL Industrials
- Exchange
- IMNM Nasdaq
- XPEL Nasdaq
- Market Cap
- IMNM 945.8M
- XPEL 984.3M
- IPO Year
- IMNM 2020
- XPEL N/A
- Fundamental
- Price
- IMNM $10.60
- XPEL $32.67
- Analyst Decision
- IMNM Strong Buy
- XPEL Strong Buy
- Analyst Count
- IMNM 5
- XPEL 1
- Target Price
- IMNM $26.40
- XPEL $58.00
- AVG Volume (30 Days)
- IMNM 965.4K
- XPEL 139.1K
- Earning Date
- IMNM 08-11-2025
- XPEL 08-06-2025
- Dividend Yield
- IMNM N/A
- XPEL N/A
- EPS Growth
- IMNM N/A
- XPEL N/A
- EPS
- IMNM N/A
- XPEL 1.71
- Revenue
- IMNM $10,938,000.00
- XPEL $434,101,000.00
- Revenue This Year
- IMNM N/A
- XPEL $11.20
- Revenue Next Year
- IMNM $259.34
- XPEL $11.18
- P/E Ratio
- IMNM N/A
- XPEL $19.22
- Revenue Growth
- IMNM N/A
- XPEL 8.38
- 52 Week Low
- IMNM $5.15
- XPEL $24.25
- 52 Week High
- IMNM $16.81
- XPEL $48.58
- Technical
- Relative Strength Index (RSI)
- IMNM 60.20
- XPEL 32.85
- Support Level
- IMNM $10.33
- XPEL $34.33
- Resistance Level
- IMNM $11.08
- XPEL $36.02
- Average True Range (ATR)
- IMNM 0.60
- XPEL 1.10
- MACD
- IMNM 0.04
- XPEL -0.32
- Stochastic Oscillator
- IMNM 72.31
- XPEL 0.00
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.